The p53 tumor suppressor gene in anticancer agent-induced apoptosis and chemosensitivity of human gastrointestinal cancer cell lines

Manabu Yamamoto, Yoshihiko Maehara, Shinya Oda, Yuji Ichiyoshi, Tetsuya Kusumoto, Keizo Sugimachi

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Purpose: While the target of many anticancer agents has been identified, the processes leading to killing of the cancer cells and the molecular basis of resistance to the drugs are not well understood. We used human gastrointestinal cancer cell lines and examined how anticancer agents induced cell killing and how the chemosensitivity of these lines was determined. Methods: Twelve gastrointestinal cancer cell lines were examined for the presence of either a wild-type or mutant p53 gene by direct sequencing. We also determined whether or not cell killing would occur when the cell lines were exposed to anticancer drugs. The sensitivity to the anticancer agents was determined based on colony formation. Results: All 12 gastrointestinal cancer cell lines carried either a wild-type or mutant p53 gene. Three lines, MKN45, MKN74 and COLO320, carried the wild-type p53 gene, and nine carried the mutant p53 gene. When three lines were exposed to the anticancer agents etoposide, doxorubicin (DXR) or 5-fluorouracil (5-FU), cell death ensued. In these cells, the population of cells in G1 phase increased after exposure to high-dose anticancer agents, but cells in G2 phase increased when exposed to low-dose anticancer agents. Our observations support the concept that cells carrying the wild-type p53 gene tend to be sensitive to etoposide and DXR and, in particular, deletion of the p53 function results in a greater resistance to anticancer agents. Conclusion: Based on our findings, human gastrointestinal cancer-related cell death apparently occurs via a p53- dependent pathway. A relationship was observed between the induction of cell death and chemosensitivity.

Original languageEnglish
Pages (from-to)43-49
Number of pages7
JournalCancer chemotherapy and pharmacology
Volume43
Issue number1
DOIs
Publication statusPublished - Feb 1 1999

Fingerprint

Gastrointestinal Neoplasms
Tumor Suppressor Genes
Antineoplastic Agents
Tumors
p53 Genes
Genes
Cells
Apoptosis
Cell Line
Cell death
Cell Death
Etoposide
Doxorubicin
G2 Phase
G1 Phase
Drug Resistance
Fluorouracil
Pharmaceutical Preparations
Population

All Science Journal Classification (ASJC) codes

  • Oncology
  • Toxicology
  • Pharmacology
  • Cancer Research
  • Pharmacology (medical)

Cite this

The p53 tumor suppressor gene in anticancer agent-induced apoptosis and chemosensitivity of human gastrointestinal cancer cell lines. / Yamamoto, Manabu; Maehara, Yoshihiko; Oda, Shinya; Ichiyoshi, Yuji; Kusumoto, Tetsuya; Sugimachi, Keizo.

In: Cancer chemotherapy and pharmacology, Vol. 43, No. 1, 01.02.1999, p. 43-49.

Research output: Contribution to journalArticle

Yamamoto, Manabu ; Maehara, Yoshihiko ; Oda, Shinya ; Ichiyoshi, Yuji ; Kusumoto, Tetsuya ; Sugimachi, Keizo. / The p53 tumor suppressor gene in anticancer agent-induced apoptosis and chemosensitivity of human gastrointestinal cancer cell lines. In: Cancer chemotherapy and pharmacology. 1999 ; Vol. 43, No. 1. pp. 43-49.
@article{192458f51642424ea2d3e9c58bf67b1a,
title = "The p53 tumor suppressor gene in anticancer agent-induced apoptosis and chemosensitivity of human gastrointestinal cancer cell lines",
abstract = "Purpose: While the target of many anticancer agents has been identified, the processes leading to killing of the cancer cells and the molecular basis of resistance to the drugs are not well understood. We used human gastrointestinal cancer cell lines and examined how anticancer agents induced cell killing and how the chemosensitivity of these lines was determined. Methods: Twelve gastrointestinal cancer cell lines were examined for the presence of either a wild-type or mutant p53 gene by direct sequencing. We also determined whether or not cell killing would occur when the cell lines were exposed to anticancer drugs. The sensitivity to the anticancer agents was determined based on colony formation. Results: All 12 gastrointestinal cancer cell lines carried either a wild-type or mutant p53 gene. Three lines, MKN45, MKN74 and COLO320, carried the wild-type p53 gene, and nine carried the mutant p53 gene. When three lines were exposed to the anticancer agents etoposide, doxorubicin (DXR) or 5-fluorouracil (5-FU), cell death ensued. In these cells, the population of cells in G1 phase increased after exposure to high-dose anticancer agents, but cells in G2 phase increased when exposed to low-dose anticancer agents. Our observations support the concept that cells carrying the wild-type p53 gene tend to be sensitive to etoposide and DXR and, in particular, deletion of the p53 function results in a greater resistance to anticancer agents. Conclusion: Based on our findings, human gastrointestinal cancer-related cell death apparently occurs via a p53- dependent pathway. A relationship was observed between the induction of cell death and chemosensitivity.",
author = "Manabu Yamamoto and Yoshihiko Maehara and Shinya Oda and Yuji Ichiyoshi and Tetsuya Kusumoto and Keizo Sugimachi",
year = "1999",
month = "2",
day = "1",
doi = "10.1007/s002800050861",
language = "English",
volume = "43",
pages = "43--49",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - The p53 tumor suppressor gene in anticancer agent-induced apoptosis and chemosensitivity of human gastrointestinal cancer cell lines

AU - Yamamoto, Manabu

AU - Maehara, Yoshihiko

AU - Oda, Shinya

AU - Ichiyoshi, Yuji

AU - Kusumoto, Tetsuya

AU - Sugimachi, Keizo

PY - 1999/2/1

Y1 - 1999/2/1

N2 - Purpose: While the target of many anticancer agents has been identified, the processes leading to killing of the cancer cells and the molecular basis of resistance to the drugs are not well understood. We used human gastrointestinal cancer cell lines and examined how anticancer agents induced cell killing and how the chemosensitivity of these lines was determined. Methods: Twelve gastrointestinal cancer cell lines were examined for the presence of either a wild-type or mutant p53 gene by direct sequencing. We also determined whether or not cell killing would occur when the cell lines were exposed to anticancer drugs. The sensitivity to the anticancer agents was determined based on colony formation. Results: All 12 gastrointestinal cancer cell lines carried either a wild-type or mutant p53 gene. Three lines, MKN45, MKN74 and COLO320, carried the wild-type p53 gene, and nine carried the mutant p53 gene. When three lines were exposed to the anticancer agents etoposide, doxorubicin (DXR) or 5-fluorouracil (5-FU), cell death ensued. In these cells, the population of cells in G1 phase increased after exposure to high-dose anticancer agents, but cells in G2 phase increased when exposed to low-dose anticancer agents. Our observations support the concept that cells carrying the wild-type p53 gene tend to be sensitive to etoposide and DXR and, in particular, deletion of the p53 function results in a greater resistance to anticancer agents. Conclusion: Based on our findings, human gastrointestinal cancer-related cell death apparently occurs via a p53- dependent pathway. A relationship was observed between the induction of cell death and chemosensitivity.

AB - Purpose: While the target of many anticancer agents has been identified, the processes leading to killing of the cancer cells and the molecular basis of resistance to the drugs are not well understood. We used human gastrointestinal cancer cell lines and examined how anticancer agents induced cell killing and how the chemosensitivity of these lines was determined. Methods: Twelve gastrointestinal cancer cell lines were examined for the presence of either a wild-type or mutant p53 gene by direct sequencing. We also determined whether or not cell killing would occur when the cell lines were exposed to anticancer drugs. The sensitivity to the anticancer agents was determined based on colony formation. Results: All 12 gastrointestinal cancer cell lines carried either a wild-type or mutant p53 gene. Three lines, MKN45, MKN74 and COLO320, carried the wild-type p53 gene, and nine carried the mutant p53 gene. When three lines were exposed to the anticancer agents etoposide, doxorubicin (DXR) or 5-fluorouracil (5-FU), cell death ensued. In these cells, the population of cells in G1 phase increased after exposure to high-dose anticancer agents, but cells in G2 phase increased when exposed to low-dose anticancer agents. Our observations support the concept that cells carrying the wild-type p53 gene tend to be sensitive to etoposide and DXR and, in particular, deletion of the p53 function results in a greater resistance to anticancer agents. Conclusion: Based on our findings, human gastrointestinal cancer-related cell death apparently occurs via a p53- dependent pathway. A relationship was observed between the induction of cell death and chemosensitivity.

UR - http://www.scopus.com/inward/record.url?scp=0032913620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032913620&partnerID=8YFLogxK

U2 - 10.1007/s002800050861

DO - 10.1007/s002800050861

M3 - Article

C2 - 9923540

AN - SCOPUS:0032913620

VL - 43

SP - 43

EP - 49

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 1

ER -